(NASDAQ: SIBN) Si Bone's forecast annual revenue growth rate of 13.6% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.57%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.48%.
Si Bone's revenue in 2026 is $213,603,000.On average, 12 Wall Street analysts forecast SIBN's revenue for 2026 to be $10,595,559,316, with the lowest SIBN revenue forecast at $10,163,508,253, and the highest SIBN revenue forecast at $10,965,760,745. On average, 12 Wall Street analysts forecast SIBN's revenue for 2027 to be $12,234,574,604, with the lowest SIBN revenue forecast at $11,595,461,724, and the highest SIBN revenue forecast at $12,974,977,463.
In 2028, SIBN is forecast to generate $14,090,063,609 in revenue, with the lowest revenue forecast at $13,176,661,050 and the highest revenue forecast at $15,110,134,376.